{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:02:26Z","timestamp":1792245746238,"version":"4.4.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>Coccidioidal meningitis remains difficult to treat. The newer triazole, isavuconazole, has demonstrated efficacy in invasive fungal disease with less side effects than other azoles. We describe a case of refractory pediatric coccidioidal meningitis with disease stabilization and improvement on isavuconazole after failing treatment with other antifungal agents.<\/jats:p>","DOI":"10.1097\/inf.0000000000003017","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T23:00:11Z","timestamp":1607986811000},"page":"e128-e131","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Isavuconazole as Salvage Therapy for Refractory Pediatric Coccidioidal Meningitis"],"prefix":"10.1097","volume":"40","author":[{"given":"Fouzia","family":"Naeem","sequence":"first","affiliation":[{"name":"Department of Infectious Disease, Valley Children\u2019s Healthcare, Madera"},{"name":"Department of Pediatrics, Stanford University School of Medicine, Stanford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Laningham","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenik","family":"Kuzmic","sequence":"additional","affiliation":[{"name":"Pharmacy, Valley Children\u2019s Healthcare, Madera, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Clerkin","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurosurgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McCarty","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stanford University School of Medicine, Stanford"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/jof5030054","article-title":"Central nervous system infections due to coccidioidomycosis.","volume":"5","author":"Jackson","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis.","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/cid\/ciw305","article-title":"Isavuconazole treatment of cryptococcosis and dimorphic mycoses.","volume":"63","author":"Thompson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R5-20250615","first-page":"163","article-title":"Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections.","volume":"6","author":"Falci","year":"2013","journal-title":"Infect Drug Resist"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/srin.2001.29298","article-title":"Intrathecal amphotericin in the management of coccidioidal meningitis.","volume":"16","author":"Stevens","year":"2001","journal-title":"Semin Respir Infect"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/ciw794","article-title":"Intrathecal amphotericin B: a 60-year experience in treating coccidioidal meningitis.","volume":"64","author":"Ho","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"suppl_1","key":"R8-20250615","doi-asserted-by":"crossref","first-page":"i12","DOI":"10.1093\/jac\/dkx029","article-title":"Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations.","volume":"72","author":"Stott","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jac\/dkz050","article-title":"Isavuconazole brain penetration in cerebral aspergillosis.","volume":"74","author":"Lamoth","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"e01292","DOI":"10.1128\/AAC.01292-17","article-title":"Tissue distribution and elimination of isavuconazole following single and repeat oral-dose administration of isavuconazonium sulfate to rats.","volume":"61","author":"Schmitt-Hoffmann","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1093\/jac\/dku148","article-title":"Amphotericin B transfer to CSF following intravenous administration of liposomal amphotericin B.","volume":"69","author":"Strenger","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s40360-018-0273-7","article-title":"Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report.","volume":"19","author":"Cornu","year":"2018","journal-title":"BMC Pharmacol Toxicol"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1097\/MPH.0000000000001508","article-title":"Isavuconazole treatment of cerebral and pulmonary aspergillosis in a pediatric patient with acute lymphoblastic leukemia: case report and review of literature.","volume":"42","author":"De Leonardis","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/INF.0000000000002671","article-title":"Isavuconazole as successful salvage therapy for mucormycosis in pediatric patients.","volume":"39","author":"Ashkenazi-Hoffnung","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13693780802562969","article-title":"In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi.","volume":"47","author":"Gonz\u00e1lez","year":"2009","journal-title":"Med Mycol"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"e02232","DOI":"10.1128\/AAC.02232-18","article-title":"Isavuconazole in the treatment of coccidioidal meningitis.","volume":"63","author":"Heidari","year":"2019","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:02:11Z","timestamp":1750003331000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003017","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,9]]}}}